Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02855242 · ClinicalTrials.gov registry record · NA

Gut Microbiota Changes in Obese Individuals Undergoing Dedicated Lifestyle Modification Programs

A NA study of Obesity, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT02855242: Completed NA study of Obesity, sponsored by Mayo Clinic.

NCT02855242 is a NA study of Obesity that has completed, run by Mayo Clinic. The registered enrollment target is 32 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02855242, a NA study of Obesity, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The human gut microbiota has become the subject of extensive research in recent years, particularly in regards to the role it plays in obesity. Although lifestyle factors, diet, and lack of exercise contribute largely to this obesity epidemic, there is increasing evidence that the human gut microbiota also influences weight gain. The investigators hope to learn more information about the change in gut microbiota, especially with regards to those who are successful with weight loss, versus those who don't lose weight, after participating in a lifestyle modification program at the Dan Abraham Healthy Living Center (DAHLC).

Primary Outcome

enrolled in exercise program

Conditions Studied

Obesity

Interventions

  • BEHAVIORAL Lifestyle Counseling
  • OTHER Controls Group

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2016-04
Est. Completion 2021-01-28
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02855242 record still lists

NCT02855242 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Counseling is the first listed.

NCT02855242 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT02855242 about?

NCT02855242 is a clinical study titled "Gut Microbiota Changes in Obese Individuals Undergoing Dedicated Lifestyle Modification Programs". The human gut microbiota has become the subject of extensive research in recent years, particularly in regards to the role it plays in obesity. Although lifestyle factors, diet, and lack of exercise contribute largely to this obesity epidemic, there is increasing evidence that the human gut microbio...

What is the current status of trial NCT02855242?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2016-04. Estimated completion is 2021-01-28.

What conditions does trial NCT02855242 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02855242?

The interventions under investigation include: Lifestyle Counseling (BEHAVIORAL), Controls Group (OTHER).

Who is sponsoring clinical trial NCT02855242?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02855242 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02855242's enrollment target sits among peer trials

32 839th of 1053 higher than 208 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT02855242, the US trial registry maintained by the National Library of Medicine. NCT02855242 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.